CJ-2360

CAT:
931-T63101-01
Size:
25 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CJ-2360 - image 1

CJ-2360

  • Target:

    Others|||ALK
  • Related Pathways:

    Others|||Tyrosine Kinase/Adaptors|||Angiogenesis
  • Bioactivity:

    CJ-2360 is a potent, orally active ALK inhibitor, capable of acting on wild-type ALK (IC50: 2.2 nM) and F1197M (IC50: 4.0 nM), G1269A (IC50: 8.8 nM), L1196M (IC50: 6.3 nM) and S1206Y ALK mutant (IC50: 8.9 nM) . CJ-2360 strongly inhibited two clinically reported ALK mutants (C1156Y and L1196M) and 468 kinases (LTK, MERTK, CLK1, DAPK1, and DAPK2) .
  • Smiles:

    O=C1C2=C (N (C (C) C) C=3C1=CC (OC) =C (C3F) N4C[C@H] (C) N (C) [C@H] (C) C4) NC=5C2=CC=C (C#N) C5
  • Molecular Formula:

    C27H30FN5O2
  • Molecular Weight:

    475.56
  • Shipping Conditions:

    Cool pack
  • Storage Temperature:

    -20°C
  • CAS Number:

    2226742-61-4